2024-12-25 - Analysis Report
## Teladoc Health Inc (TDOC) Stock Review

**1. Performance Comparison and Divergence:**

Teladoc Health (TDOC) significantly underperformed the S&P 500 (VOO) over the observed period.  The cumulative return for TDOC is -67.19%, while VOO's is 116.66%. This represents a substantial divergence of -183.85%.  The provided relative divergence of 0.2 indicates that TDOC's performance is near the lower bound of its historical range relative to VOO.

Teladoc Health Inc. is a telehealth company providing virtual healthcare services.


**2. Recent Price Movement:**

* **Closing Price:** $9.44
* **Last Market Price:** $9.26
* **5-Day Moving Average:** $9.72
* **20-Day Moving Average:** $10.69
* **60-Day Moving Average:** $9.66

The stock is currently trading below its 5, 20, and 60-day moving averages, suggesting a bearish trend.  The last market price of $9.26 is slightly below the closing price and reflects recent downward pressure.

**3. Technical Indicators and Expected Return:**

* **RSI (27.21):**  Indicates the stock is in oversold territory, suggesting potential for a bounce but not confirming a reversal.
* **PPO (-2.44):**  Shows a bearish momentum.
* **Relative Divergence Change (-0.2):**  Confirms a recent short-term downward trend.
* **Expected Return (0.0%):** The provided expected return of 0.0% suggests no significant outperformance relative to the S&P 500 is expected over a long-term (2+ years) buy-and-hold strategy.  This is consistent with the significant underperformance already observed.

**4. Recent Earnings Analysis:**

The provided earnings data reveals a consistent trend of negative EPS and relatively flat revenue.  There's no clear revenue growth; it fluctuates around $0.64-$0.66 billion.  EPS has been consistently negative across all reported quarters, with particularly significant losses in Q2 2024 (-$4.92).  There is no information on earnings expectations for comparison.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remains relatively stable, but profit margins are high despite negative EPS, suggesting potential accounting practices that deserve further investigation.  High profit margins paired with negative earnings needs clarification (potentially due to non-GAAP metrics or significant non-cash charges).
* **Capital and Profitability:** Equity has fluctuated, and Return on Equity (ROE) is consistently negative, indicating the company is not generating returns for its shareholders.  The negative ROE is of significant concern.

**6. News and Recent Issues:**  (No recent news or analyst opinions are provided).  Information on recent earnings news, market outlook, and analyst opinions is needed to complete this section.

**7. Overall Analysis:**

TDOC's performance has significantly underperformed the S&P 500, showing a substantial negative return. Technical indicators suggest oversold conditions, but the negative EPS, negative ROE, flat revenue, and a bearish trend are all significant concerns.  The high profit margin alongside negative EPS requires further investigation to understand the underlying accounting practices.  Without additional information (especially analyst sentiment and news regarding recent earnings),  a strong bearish outlook is indicated.  A long-term investment strategy in TDOC should only be considered after a thorough fundamental analysis, given the substantial underperformance and questionable financial metrics.  More information on recent news and market outlook is crucial for a complete assessment.

**8. Disclaimer:** This analysis is based solely on the provided data.  It does not constitute financial advice.  Consult with a qualified financial advisor before making any investment decisions.  Further research into the company's fundamentals, competitive landscape, and future prospects is highly recommended.
